Skip to main content
Log in

Swallowable Obalon® Gastric Balloons as an Aid for Weight Loss: A Pilot Feasibility Study

  • Brief Communication
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

The goal of this study was to evaluate the safety and the impact on weight loss of a new swallowable gastric balloon. In this prospective pilot study, 17 overweight or obese patients were included. Up to three balloons were ingested under fluoroscopic control. All balloons were removed by upper GI endoscopy, 12 weeks after the ingestion of the first balloon. 43 out of 44 attempts (98 %) to swallow a balloon were successful. Nausea and stomach pain were the most frequent side effects. Endoscopic procedures for balloon removal were uneventful. Weight loss was significant at weeks 4, 8, and 12. This pilot study showed no significant side effects induced by up to three balloons, and a significant weight loss.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Genco A, Bruni T, Doldi SB, et al. BioEnterics intragastric balloon: the Italian experience with 2,515 patients. Obes Surg. 2005;15:1161–4.

    Article  PubMed  CAS  Google Scholar 

  2. Roman S, Napoleon B, Mion F, et al. Intragastric balloon for "non-morbid" obesity: a retrospective evaluation of tolerance and efficacy. Obes Surg. 2004;14:539–44.

    Article  PubMed  Google Scholar 

  3. Dumonceau JM. Evidence-based review of the Bioenterics intragastric balloon for weight loss. Obes Surg. 2008;18:1611–7.

    Article  PubMed  Google Scholar 

  4. Genco A, Balducci S, Bacci V, et al. Intragastric balloon or diet alone? A retrospective evaluation. Obes Surg. 2008;18:989–92.

    Article  PubMed  Google Scholar 

  5. Sacks FM, Bray GA, Carey VJ, et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med. 2009;360:859–73.

    Article  PubMed  CAS  Google Scholar 

  6. Messina T, Genco A, Favaro R, et al. Intragastric balloon positioning and removal: sedation or general anesthesia? Surg Endosc. 2011;25:3811–4.

    Article  PubMed  Google Scholar 

  7. Machytka E, Klvana P, Kornbluth A, et al. Adjustable intragastric balloons: a 12-month pilot trial in endoscopic weight loss management. Obes Surg. 2011;21:1499–507.

    Article  PubMed  Google Scholar 

  8. Mion F, Gincul R, Roman S, et al. Tolerance and efficacy of an air-filled balloon in non-morbidly obese patients: results of a prospective multicenter study. Obes Surg. 2007;17:764–9.

    Article  PubMed  Google Scholar 

  9. Lecumberri E, Krekshi W, Matia P, et al. Effectiveness and safety of air-filled balloon Heliosphere BAG® in 82 consecutive obese patients. Obes Surg. 2011;21:1508–12.

    Article  PubMed  Google Scholar 

  10. Ofman JJ, Rabeneck L. The effectiveness of endoscopy in the management of dyspepsia: a qualitative systematic review. Am J Med. 1999;106:335–46.

    Article  PubMed  CAS  Google Scholar 

  11. Peker Y, Durak E, Ozgurbuz U. Intragastric balloon treatment for obesity: prospective single-center study findings. Obes Facts. 2010;3:105–8.

    Article  PubMed  Google Scholar 

  12. Dastis NS, Francois E, Deviere J, et al. Intragastric balloon for weight loss: results in 100 individuals followed for at least 2.5 years. Endoscopy. 2009;41:575–80.

    Article  PubMed  Google Scholar 

  13. Martin CK, Bellanger DE, Rau KK, Coulon S, Greenway FL. Safety of the Ullorex oral intragastric balloon for the treatment of obesity. J Diabetes Sci Technol. 2007;1:574–81.

    PubMed  Google Scholar 

Download references

Acknowledgment

The study was sponsored by Obalon Therapeutics Inc. (Carlsbad, CA, USA). FM, TP, JD received honoraria for the study.

Conflict of Interest

The other authors declared no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to François Mion.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mion, F., Ibrahim, M., Marjoux, S. et al. Swallowable Obalon® Gastric Balloons as an Aid for Weight Loss: A Pilot Feasibility Study. OBES SURG 23, 730–733 (2013). https://doi.org/10.1007/s11695-013-0927-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-013-0927-x

Keywords

Navigation